+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Phase 3
Age: 1Year - 17Years
All Genders
ID07159841

Evaluating Atumelnant Treatment in Children With Classic Congenital Adrenal Hyperplasia Including a Long-Term Extension

Led by Crinetics Pharmaceuticals Inc. · Updated on 2026-10-16

153

Participants Needed

51

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating atumelnant treatment for safety, effectiveness, how the body processes it, and its effects in children with classic congenital adrenal hyperplasia CAH. This Phase 23 study includes an open-label extension and aims to help understand this treatment in pediatric patients aged 1 to under 18 years with classic CAH. The study has multiple parts, including early open-label cohorts, a randomized, placebo-controlled phase, and a long-term extension. Participants receive atumelnant tablets once daily by mouth, with doses based on weight. Part A involves open-label, semi-sequential cohorts starting with ages 12 to under 18 years, followed by ages 1 to 11 years after safety reviews. Part B is a double-blind phase with participants randomly assigned to either atumelnant or placebo. Those who complete Parts A or B may join Part C, an open-label extension period to continue receiving treatment. During the study, participants undergo evaluations including blood tests to measure hormone levels like serum androstenedione and 17-hydroxyprogesterone, pharmacokinetics, and pharmacodynamics. Researchers track changes in glucocorticoid doses and hormone levels over time to assess treatment impact. The study includes safety monitoring and long-term follow-up for up to nearly five years. Total participation lasts until study completion in March 2030.

CONDITIONS

Brief Title

A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)

Research Team

C

Crinetics Clinical Trials

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here